Vanderbilt’s VICTR--$51M to Pave Innovative Pathway to Improved Clinical Trials

A team based in Vanderbilt Institute for Clinical and Translational Research (VICTR) secured two five-year federal grants totaling $51 million to harness new and existing approaches for boosting recruitment and removing roadblocks to the efficiency of conducting clinical trials throughout the country. A major grant award, VICTR emerges as a trend setter in the realm of clinical trials.
The grants, from the National Center for Advancing Translational Sciences, part of the National Institutes of Health (NIH), recognize the expertise, leadership and plethora of clinical research tools developed over the past several years at VICTR, home of Vanderbilt University Medical Center&rsquo;s NIH-funded Clinical and Translational Science Award (CTSA).